Viking Therapeutics Inc (VKTX)

NASDAQ HEALTHCARE
$38.86 -5.54% RSI 59 Neutral Add Alert

Moving Averages

SMA 200
$33.31
Price above

Company Profile

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered in San Diego, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$4.51B
P/E Ratio
None
EPS
$-4.15
Beta
0.655
Dividend Yield
0.00%
52-Week High
$43.15
52-Week Low
$22.96

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 44.0
VRTX
Vertex Pharmaceuticals Inc
RSI 51.0
CRSP
CRISPR Therapeutics AG
RSI 41.0
MRNA
Moderna Inc
RSI 55.0
SRPT
Sarepta Therapeutics Inc
RSI 56.0
EDIT
Editas Medicine Inc
RSI 55.0
IOVA
Iovance Biotherapeutics Inc
RSI 48.0
NVAX
Novavax Inc
RSI 51.0
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 49.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 52.0

Data last updated: July 13, 2026 at 1:41 AM EDT

Track VKTX for free

Get e-mail RSI alerts when Viking Therapeutics Inc enters oversold or overbought territory. Free forever.

Add Alert